BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2023-02-03 00:00 |
Jahresabschluss zum Geschäftsjahr vom 01.10.2021 bis zum 30.09.2022
|
German | ZIP • 620.8 KB | ||
| 2023-02-03 00:00 |
Konzernabschluss zum Geschäftsjahr vom 01.10.2021 bis zum 30.09.2022
|
German | ZIP • 1.1 MB | ||
| 2023-01-27 15:05 |
BRAIN Biotech AG: Bekanntmachung der Einberufung zur Hauptversammlung am 08.03.…
|
German | HTML • 348.2 KB | ||
| 2023-01-17 00:00 |
Annual financial report 2021/2022
|
English | PDF • 3.5 MB | ||
| 2023-01-16 07:30 |
BRAIN Biotech AG reports record figures in fiscal year 2021/22 despite challen…
|
English | HTML • 15.3 KB | ||
| 2023-01-10 12:15 |
BRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the …
|
English | HTML • 12.0 KB | ||
| 2023-01-10 12:10 |
BRAIN Biotech AG: prioritizing development of therapeutic applications of the A…
|
English | HTML • 7.8 KB | ||
| 2023-01-09 14:41 | English | HTML • 4.5 KB | |||
| 2023-01-09 12:10 |
BRAIN Biotech AG: Key Leadership Appointments at BRAIN Biotech AG, Zwingenberg …
|
English | HTML • 11.5 KB | ||
| 2023-01-09 00:00 |
Hinweis auf Jahresfinanzbericht vom 01.10.2021 bis zum 30.09.2022
|
German | HTML • 5.8 KB | ||
| 2022-11-22 20:59 | English | HTML • 14.4 KB | |||
| 2022-11-17 10:00 |
BRAIN Biotech AG: MP Beteiligungs-GmbH Increases Stake in BRAIN Biotech AG
|
English | HTML • 10.4 KB | ||
| 2022-10-25 09:30 |
BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare mo…
|
English | HTML • 12.1 KB | ||
| 2022-10-13 15:41 |
EQS-DD: BRAIN Biotech AG english
|
English | HTML • 8.1 KB | ||
| 2022-10-13 14:59 |
EQS-DD: BRAIN Biotech AG english
|
English | HTML • 9.3 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
